Cannabidiol in Neurology and Psychiatry, Volume 177 in the International Review in Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on topic such as Historical perspective on the therapeutic potential of cannabidiol, Cannabidiol: pharmacodynamics pharmacokinetic, Cannabidiol and Alzheimer’s disease, Cannabidiol on anxiety disorders, Cannabidiol on psychosis, Cannabidiol on autism spectrum disorders, Cannabidiol in Epilepsy, Cannabidiol in Ischemia/stroke, Cannabidiol in Depression, Cannabidiol and Abuse of drugs, and much more.
Additional chapters cover Cannabidiol in fear response and PTSD, Cannabidiol and Pain. and Cannabidiol and Parkinson’s disease.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Preface - p. xv 8. Chapter One: Historical perspective on the therapeutic potential of cannabidiol - p. 1 9. Chapter Two: Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders - p. 11 10. Chapter Three: Cannabidiol and pain - p. 29 11. Chapter Four: A journey through cannabidiol in Parkinson’s disease - p. 65 12. Chapter Five: Cannabidiol in experimental cerebral ischemia - p. 95 13. Chapter Six: Cannabidiol and Alzheimer’s disease - p. 121 14. Chapter Seven: Cannabidiol and epilepsy - p. 135 15. Chapter Eight: Therapeutic potential of CBD in Autism Spectrum Disorder - p. 149 16. Chapter Nine: Cannabidiol in anxiety disorders: Current and future perspectives - p. 205 17. Chapter Ten: Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies - p. 235 18. Chapter Eleven: Therapeutic potential of cannabidiol in depression - p. 251 19. Chapter Twelve: Cannabidiol as an antipsychotic drug - p. 295 20. Chapter Thirteen: Cannabidiol and addiction - p. 319
Cannabidiol in Neurology and Psychiatry, Volume 177 in the International Review in Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on topic such as Historical perspective on the therapeutic potential of cannabidiol, Cannabidiol: pharmacodynamics pharmacokinetic, Cannabidiol and Alzheimer’s disease, Cannabidiol on anxiety disorders, Cannabidiol on psychosis, Cannabidiol on autism spectrum disorders, Cannabidiol in Epilepsy, Cannabidiol in Ischemia/stroke, Cannabidiol in Depression, Cannabidiol and Abuse of drugs, and much more.
Additional chapters cover Cannabidiol in fear response and PTSD, Cannabidiol and Pain. and Cannabidiol and Parkinson’s disease.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Preface - p. xv 8. Chapter One: Historical perspective on the therapeutic potential of cannabidiol - p. 1 9. Chapter Two: Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders - p. 11 10. Chapter Three: Cannabidiol and pain - p. 29 11. Chapter Four: A journey through cannabidiol in Parkinson’s disease - p. 65 12. Chapter Five: Cannabidiol in experimental cerebral ischemia - p. 95 13. Chapter Six: Cannabidiol and Alzheimer’s disease - p. 121 14. Chapter Seven: Cannabidiol and epilepsy - p. 135 15. Chapter Eight: Therapeutic potential of CBD in Autism Spectrum Disorder - p. 149 16. Chapter Nine: Cannabidiol in anxiety disorders: Current and future perspectives - p. 205 17. Chapter Ten: Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies - p. 235 18. Chapter Eleven: Therapeutic potential of cannabidiol in depression - p. 251 19. Chapter Twelve: Cannabidiol as an antipsychotic drug - p. 295 20. Chapter Thirteen: Cannabidiol and addiction - p. 319
